Literature DB >> 11404791

Vas deferens, a site of male contraception: an overview.

N K Lohiya1, B Manivannan, P K Mishra, N Pathak.   

Abstract

The vas deferens is a site which can be exploited for male contraception without undue side effects. The only effective technique available for male contraception is vasectomy, being practiced world wide, despite that it is a permanent surgical procedure and its successful reversal is not assured. Although no-scalpel vasectomy minimizes surgical procedures, the fate of its reversal is akin to that of vasectomy. Several occlusive and non-occlusive vasal procedures which claim to be reversible without surgical intervention, possess more disadvantages than advantages. Vas occlusion with plug, 'Shug' or medical grade silicone rubber, although claimed to produce reversible azoospermia without affecting spermatogenesis, requires skilled microsurgery for their implantation and later removal. RISUG, a non-sclerotic polymer styrene maleic anhydride (SMA), could be more advantageous than vasectomy and other vas occlusive procedures in that it could be a totally non-invasive procedure by "no-scalpel injection" and "non-invasive reversal". It is claimed to offer long-term contraception without adverse side effects and also to be possible as a male spacing method by repeated vas occlusion and non-invasive reversal. The drug is currently under multicentre Phase III clinical trial.

Entities:  

Mesh:

Year:  2001        PMID: 11404791

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  5 in total

Review 1.  As the world grows: contraception in the 21st century.

Authors:  R John Aitken; Mark A Baker; Gustavo F Doncel; Martin M Matzuk; Christine K Mauck; Michael J K Harper
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Prognostic value of intraoperative parameters observed during vasectomy reversal for predicting postoperative vas patency and fertility.

Authors:  Stefan Hinz; Soroush Rais-Bahrami; Wolf H Weiske; Carsten Kempkensteffen; Mark Schrader; Kurt Miller; Ahmed Magheli
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

3.  Contraception with RISUG® and functional reversal through DMSO and NaHCO3 in male rabbits.

Authors:  Abdul S Ansari; Ayesha Badar; Krithika Balasubramanian; Nirmal K Lohiya
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285

4.  Azoospermia in rabbits following an intravas injection of Vasalgel ™.

Authors:  Donald Waller; David Bolick; Elaine Lissner; Christopher Premanandan; Gary Gamerman
Journal:  Basic Clin Androl       Date:  2016-03-30

5.  The contraceptive efficacy of intravas injection of Vasalgel™ for adult male rhesus monkeys.

Authors:  Angela Colagross-Schouten; Marie-Josee Lemoy; Rebekah I Keesler; Elaine Lissner; Catherine A VandeVoort
Journal:  Basic Clin Androl       Date:  2017-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.